Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ventas, Inc. Director's Dealing 2017

Mar 2, 2017

30143_dirs_2017-03-02_3b8e121a-aa76-4ab2-a42b-eab1a3a006e6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VENTAS INC (VTR)
CIK: 0000740260
Period of Report: 2017-02-28

Reporting Person: Lillibridge Todd W. (EVP, Medical Prop. Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-02-28 Common Stock M 9459 $45.03 Acquired 144997.043 Direct
2017-02-28 Common Stock S 9459 $65.0227 Disposed 135538.043 Direct
2017-02-28 Common Stock M 29631 $46.88 Acquired 165169.043 Direct
2017-02-28 Common Stock S 29631 $65.0227 Disposed 135538.043 Direct
2017-02-28 Common Stock M 32058 $55.50 Acquired 167596.043 Direct
2017-02-28 Common Stock S 32058 $65.0227 Disposed 135538.043 Direct
2017-02-28 Common Stock M 71211 $51.85 Acquired 206749.043 Direct
2017-02-28 Common Stock S 71211 $65.0227 Disposed 135572.246 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-02-28 Stock Option (Right to Buy) $45.03 M 9459 Acquired 2021-01-20 Common Stock (9459.0) Direct
2017-02-28 Stock Option (Right to Buy) $46.88 M 29631 Acquired 2022-01-18 Common Stock (29631.0) Direct
2017-02-28 Stock Option (Right to Buy) $55.5 M 32058 Acquired 2023-01-23 Common Stock (32058.0) Direct
2017-02-28 Stock Option (Right to Buy) $51.85 M 71211 Acquired 2024-01-29 Common Stock (71211.0) Direct

Footnotes

F1: On February 28, 2017, the Reporting Person transmitted to the Securities and Exchange Commission (the "SEC") a Form 144 covering the sale of the Issuer's common stock reported in Table I. The price reported in column 4 is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $65.00 to $65.185, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1).

F2: Includes 34.203 shares acquired between January 18, 2017 and February 28, 2017 under the Ventas Employee and Director Stock Purchase Plan.

F3: These options were part of a previously reported grant by the Issuer to the Reporting Person which vested in three equal annual installments beginning on the date of grant.